Sanada, Junpei
Obata, Atsushi
Fushimi, Yoshiro
Kimura, Tomohiko
Shimoda, Masashi
Ikeda, Tomoko
Nogami, Yuka
Obata, Yoshiyuki
Yamasaki, Yuki
Nakanishi, Shuhei
Mune, Tomoatsu
Kaku, Kohei
Kaneto, Hideaki
Article History
Received: 6 May 2022
Accepted: 28 July 2022
First Online: 2 August 2022
Competing interests
: H.K. has received honoraria for lectures, received scholarship grants, and received research grant from Novo Nordisk Pharma, Sanofi, Eli Lilly, Boehringer Ingelheim, Taisho Pharma, Sumitomo Pharma, Takeda Pharma, Ono Pharma, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Kissei Pharma, MSD, AstraZeneca, Astellas, Novartis, Kowa, Abbott. K.K. has been an advisor to, received honoraria for lectures from, and received scholarship grants from Novo Nordisk Pharma, Sanwa Kagaku, Takeda, Taisho Pharma, MSD, Kowa, Sumitomo Pharma, Novartis, Mitsubishi Tanabe Pharma, AstraZeneca, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Sanofi. The other authors declare no competing interests.